Advertisement

Topics

Arrowhead Publishers and Conferences Company Profile

22:35 EST 11th December 2018 | BioPortfolio


News Articles [391 Associated News Articles listed on BioPortfolio]

J&J Bets Big On Arrowhead’s Early Promise In Hepatitis B

The pharma is paying $250m up front for worldwide rights to Arrowhead’s Phase I/II RNAi candidate. Arrowhead says letting J&J...   

Arrowhead refills its quiver

Arrowhead’s RNAi toxicity setback in 2016 gave it a jumpstart on a safer and more versatile platform.

Janssen Reaches $250M Deal for Rights to Arrowhead’s Hep B RNAi Drug

Arrowhead Pharmaceuticals is licensing one of its drug candidates, a hepatitis B treatment, to a subsidiary of pharmaceutical giant Johnson & Johnson in a cash and stock deal valued at $250 millio...

Arrowhead, Janssen sign $3.7bn license and collaboration deal

ARO-HBV is the third generation subcutaneously administered RNA interference (RNAi) therapeutic of Arrowhead being developed as a potential curative therapy for patients with chronic HBV infection. Th...

Arrowhead, Janssen pen deal worth up to $3.7bn

In a deal potentially worth $3.7bn, Arrowhead Pharmaceuticals Inc. licensed Janssen Pharmaceuticals Inc. exclusive worldwide rights to develop and commercialize its ARO-HBV program. In addition, Janss...

Arrowhead ends enrolment in AROAAT1001 trial

Arrowhead Pharmaceuticals has completed patient enrolment in the Phase l AROAAT1001 trial of ARO-AAT for Treatment of Alpha-1 Liver Disease....Read More... The post Arrowhead ends enrolment in AROAAT1...

Janssen signs $3.7bn licence agreements with Arrowhead

Janssen Pharmaceuticals has signed a $3.7bn licence and collaboration agreement with Arrowhead Pharmaceuticals for the development and commercialisation of a...Read More... The post Janssen signs $3.7...

Arrowhead reports on initial data from RNAi therapy study for HBV

Arrowhead Pharmaceuticals' third-generation RNA interference therapy candidate ARO-HBV decreased circulating hepatitis B viru -More- 

Drugs and Medications [7 Associated Drugs and Medications listed on BioPortfolio]

Creon [Abbott Products, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON.CREON (pancrelipase) delayed-release capsules for oral useIni...

Pancreaze [Ortho-McNeil-Janssen Pharmaceutical, Inc.]

These highlights do not include all the information needed to use PANCREAZE™ safely and effectively. See full prescribing information for PANCREAZE™.  PANCREAZE™ (pancrelipase) delayed-release ...

Creon [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use CREON safely and effectively. See full prescribing information for CREON. CREON (pancrelipase) capsule, delayed release for oral use I...

Pancrelipase [X-GEN Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use pancrelipase safely and effectively. See full prescribing information for pancrelipase. pancrelipase (pancrelipase) CAPSULE, DELAYED R...

Zenpep [Eurand Pharmaceuticals Inc.]

These highlights do not include all the information needed to use ZENPEP safely and effectively. See full prescribing information for ZENPEP. ZENPEP (pancrelipase) delayed release capsules Initial U.S...

PubMed Articles [53 Associated PubMed Articles listed on BioPortfolio]

A data citation roadmap for scientific publishers.

This article presents a practical roadmap for scholarly publishers to implement data citation in accordance with the Joint Declaration of Data Citation Principles (JDDCP), a synopsis and harmonization...

A Seat at the Table: The Positioning of Families During Care Conferences in Nursing Homes.

Current nursing home policy emphasizes the need for collaborative, team-based care planning in which families and/or residents are actively involved. Resident care conferences are common where care pr...

Morbidity and mortality conferences : Structure and clinical experiences.

Morbidity and mortality conferences (M & M) have become increasingly more important in Germany in recent years as an important risk management tool; however, in addition to risk identification M &...

Case conferences for infective endocarditis: A quality improvement initiative.

A multidisciplinary approach has been recommended for the management of patients with infective endocarditis. We evaluated the impact of multidisciplinary case conferences on morbidity, mortality, and...

All publishers are predatory - some are bigger than others.

Clinical Trials [26 Associated Clinical Trials listed on BioPortfolio]

Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences (OPEN : Organization, Practices Evaluation in Perinatal Network)

This cluster-randomised controlled trial will test the hypothesis that a multifaceted program with psychological intervention in morbidity mortality conferences (MMC) improve care quality ...

The Effect of Case Conferencing in Nursing Homes

This study evaluates the effect of using comprehensive geriatric assessment in combination with case conferences on the prevalence of neuropsychiatric symptoms (also known as behavioral an...

How Does the Spirituality of Patients With Type 2 Diabetes Influence Their Self-management?

This exploratory study is researching how the spirituality of a group of British patients with type 2 diabetes (T2D), impacts their approach to the self-management of their condition. ...

Yoga for Persistent Pain Related to Oncology Surgery

This randomized controlled trial will evaluate a yoga intervention for individuals who experience persistent pain following oncology surgery. The integrated yoga program will involve postu...

Oxidative Stress In Semen And Male Infertility

The proposed research aims to study the effects of antioxidant therapy, commonly used in male infertility treatment, on semen analysis. Patients presenting with male infertility, who are f...

Companies [272 Associated Companies listed on BioPortfolio]

Arrowhead Publishers & Conferences

Arrowhead Publishers and Conferences

Arrowhead Publishers

Arrowhead Publishers is a leader in business intelligence and market research reports for the pharmaceutical and biotech industries. Our reports offer readers a blend of information, insight, analysis...

Arrowhead Research Corporation

Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life sciences and electronic...

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes...

More Information about "Arrowhead Publishers and Conferences" on BioPortfolio

We have published hundreds of Arrowhead Publishers and Conferences news stories on BioPortfolio along with dozens of Arrowhead Publishers and Conferences Clinical Trials and PubMed Articles about Arrowhead Publishers and Conferences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arrowhead Publishers and Conferences Companies in our database. You can also find out about relevant Arrowhead Publishers and Conferences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record